An ideal influenza vaccine must have two essential attributes: one, it should be capable of inducing broadly cross-reactive antibodies that can neutralize diverse influenza virus strains; and two, it must induce long-lived antibody responses to maintain protective immunity for extended periods. The licensed inactivated influenza virus vaccine does neither ? the antibody response is of limited breadth and vaccine-induced immunity appears to be of short duration. Our preliminary results show that the currently used seasonal inactivated trivalent influenza vaccine (TIV) is not efficient in generating long-lived bone marrow plasma cells in humans and that this is the cellular defect that underlies the waning immunity seen after influenza vaccination. In addition, our recent data suggest that there is minimal somatic hypermutation in influenza-specific B cells after immunization with TIV. This suggests that the vaccine fails to elicit the robust germinal center responses that are thought to be required for generating long-lived plasma cells. As we move towards the goal of developing a ?Universal? influenza vaccine, there is a compelling need for a product that will provide long-lasting protection against many different strains of influenza viruses. Previous studies have shown that some live attenuated viral vaccines or infections are able to induce antibody responses that persist for a lifetime in humans, while responses to protein vaccines typically decline much faster. This suggests that there are qualitative differences in the plasma cells elicited by live versus inactivated vaccines. Our proposal addresses fundamental questions about the generation of influenza-specific long-lived plasma cells and their persistence in the bone marrow both in humans and in mice following vaccination or infection. The following specific aims are proposed:
Specific Aim 1; To determine the duration of humoral immunity to influenza virus infection versus vaccination in humans;
and Specific Aim 2 : To optimize strategies for using adjuvants and the vaccine candidates developed in this program project to generate long lived bone marrow plasma cells in mice. Our studies will be highly synergistic with other projects and cores in this Program Project grant.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI097092-06A1
Application #
9571694
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Fulton, Benjamin O; Sun, Weina; Heaton, Nicholas S et al. (2018) The Influenza B Virus Hemagglutinin Head Domain Is Less Tolerant to Transposon Mutagenesis than That of the Influenza A Virus. J Virol 92:
Coughlan, Lynda; Palese, Peter (2018) Overcoming Barriers in the Path to a Universal Influenza Virus Vaccine. Cell Host Microbe 24:18-24
Henry, Carole; Palm, Anna-Karin E; Krammer, Florian et al. (2018) From Original Antigenic Sin to the Universal Influenza Virus Vaccine. Trends Immunol 39:70-79
Broecker, Felix; Liu, Sean T H; Sun, Weina et al. (2018) Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice. J Virol 92:
Bailey, Mark J; Broecker, Felix; Leon, Paul E et al. (2018) A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies. J Vis Exp :
Stamper, Christopher T; Wilson, Patrick C (2018) What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Is Affinity Maturation a Self-Defeating Process for Eliciting Broad Protection? Cold Spring Harb Perspect Biol 10:
Ajmani, Gaurav S; Suh, Helen H; Wroblewski, Kristen E et al. (2017) Smoking and olfactory dysfunction: A systematic literature review and meta-analysis. Laryngoscope 127:1753-1761
Leon, Paul E; Wohlbold, Teddy John; He, Wenqian et al. (2017) Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies. J Vis Exp :
He, Wenqian; Chen, Chi-Jene; Mullarkey, Caitlin E et al. (2017) Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice. Nat Commun 8:846
Martín-Vicente, María; Medrano, Luz M; Resino, Salvador et al. (2017) TRIM25 in the Regulation of the Antiviral Innate Immunity. Front Immunol 8:1187

Showing the most recent 10 out of 86 publications